Biofrontera Inc. – Filings and Transcripts

NASDAQ: BFRI
Share price (9/21/26): $1.16
Market cap (9/21/26): $17.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 12/31/25 FY 2025 – amended

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Initial registration of new securities

Initial registration of new securities – amended

Initial registration of new securities

Exempt offering of securities

Ownership Filter

Rosalind Advisors, Inc.

Luebbert Hermann

Leffler Eugene Frederick

Weber Kevin Daniel

Luebbert Hermann

News Filter

Announces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell Carcinoma

Reports Strong Second Quarter 2026 Financial Results Driven by 33% Revenue Growth

Shareholder Vote Results

Reports First Quarter 2026 Financial Results and Provides a Business Update

Conference Call Will Be Held Today, Thursday, March 19 at 10:00 Am ET

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Notice of effectiveness

Correspondence with the SEC

Notice of effectiveness